Who are we & what's our mission
Novosanis is an innovative developer and producer of medical devices adding value to the accuracy of diagnostics tests as well as drug delivery in the field of prevention, detection and treatment of infectious diseases and oncology.
Novosanis is a Belgian company endorsed on multiple occasions nationally and internationally for its solutions and is ISO13485 certified.
Novosanis prospers in user-friendly and clever medical devices meeting all regulatory and quality requirements for self-sampling and drug delivery solutions that improve accuracy and standardization while making handling easier, more consistent and more comfortable for the user.
We have two device platforms in portfolio:
VAX-ID™ is a patented and proven platform of injection devices suited for accurate drug delivery of e.g. therapeutic, prophylactic and allergy vaccines in the dermal layer of the skin and
Colli-Pee™is a patented sampling device suited for standardized and guaranteed collection of first-void urine (first 20ml of the urine flow) allowing improved detection of infectious diseases as well as early stage cancer. Colli-Pee™ is in a commercial stage. It is CE-marked and FDA listed
What we've been up to
Aim: Performance of a new first-void collection device, Colli-Pee™
- Group A: 32 women, positive for HPV16 and/or 18 at earlier testing (HPV DNA on cervical samples).
- Group B: 155 healthy volunteers (50 men, 105 women), HPV status unknown.
- Detection of hDNA and HPV DNA in (first void) urine collected using Colli-Pee™ (Novosanis) and Multi-Collect™ (Abbott).
- Group A samples were send back by regular mail
Conclusion: In women, urine collected using the Colli-Pee™device yielded a higher number of copies of hDNA and HPV DNA compared to the Abbott Multi-Collect™ system. As all samples of group A arrived at the lab in good conditions, self-sampling at home using the Colli-Pee™ is proven to be a valuable tool.